Cart
sales@molnova.com
Benzalphthalide
CAS No. 575-61-1
Benzalphthalide( NSC 2824 | NSC-2824 | NSC2824 )
Catalog No. M27278 CAS No. 575-61-1
Benzalphthalide is a chemical compound with anti-HIV activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzalphthalide
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzalphthalide is a chemical compound with anti-HIV activity.
-
DescriptionBenzalphthalide is a chemical compound with anti-HIV activity.
-
In Vitro——
-
In Vivo——
-
SynonymsNSC 2824 | NSC-2824 | NSC2824
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorKRAS G12C
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number575-61-1
-
Formula Weight222.243
-
Molecular FormulaC15H10O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (224.98 mM)
-
SMILESO=C1O\C(=C/c2ccccc2)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nakayama A, et al. Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models. Br J Cancer. 2021 Nov 18.
molnova catalog
related products
-
NBD-556
A potent HIV-1 entry inhibitor that blocks the gp120-CD4 interaction.
-
Apelin-36 (rat, mous...
Endogenous APJ receptor agonist that is secreted by adipocytes. Binds with high affinity to APJ receptors (IC50 = 5.4 nM) and potently inhibits cAMP production in vitro (EC50 = 0.52 nM). Involved in regulation of cardiovascular function, fluid homeostasis and feeding. Blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ.
-
HIV-1 integrase inhi...
HIV-1 integrase inhibitor 8 is an inhibitor of HIV-1 integrase, a critical enzyme necessary for the integration step in HIV replication .
